LNAILunai Bioworks Inc.
$5.05
$0.235
(9.00%)
Closed $2.85
$2.21
(77.50%)
After Hours
EarningsSep 28
Mkt Cap$11.83M
Vol19.13M
Fundamentals
84
Extremely Bullish Sentiment
How do you feel about LNAI?
Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration
Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration PR Newswire SACRAMENTO, Calif. and SAN DIEGO, May...
PR Newswire
Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock
Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock PR Newswire WASHINGTON, May 22, 2026 WASHINGTON, May 22, 2026...
PR Newswire
LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT
LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT PR Newswire SACRAMENTO, Calif., May 20, 2026 SACRAMENTO, Calif., May 20, 2026 /PRNewswire/ --Lunai Bioworks, Inc. (Nasdaq: LNAI) (the "Company") today announced that it will effect a reverse stock...
PR Newswire
Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP
Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and...
PR Newswire
Stock Market Today: Dow Jones, S&P 500 Futures Edge Lower Amid Extension Of Israel-Lebanon Ceasefire Intel, SAP, Lunai Bioworks In Focus
U.S. stock futures were mixed on Friday following Thursday's decline, after President Donald Trump announced the extension of the ceasefire between Israel and Lebanon by three weeks. On Thursday, the...
Benzinga
Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships
Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient...
PR Newswire
Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion
Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under...
PR Newswire
AI, Biotech, and Defense Converge: Small Caps Chase Big Markets as Innovation Narrative Heats Up
Today's top stocks include $LNAI, $HCTI, $TGNT, $KOD, $NAVN, $BTBD
24-7 Market News
Lunai Bioworks Unveils AI-Driven National Consortium to Fast-Track Chemical Defense Countermeasures
Lunai Bioworks (NASDAQ:LNAI) launched a new national consortium aimed at transforming how the United States develops medical countermeasures against emerging chemical threats. Operating through its subsidiary BioSymetrics, the company introduced the Pathfinder Consortium, an academic-industry alliance designed to unify historically fragmented chemical defense efforts across government, academia, and biotech into a single, execution-focused platform.
24-7 Market News
<
1
2
...
>
Advertisement|Remove ads.
Latest LNAI News
ViewLunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration
PR Newswire
Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock
PR Newswire
LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT
PR Newswire
Advertisement|Remove ads.